A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: Implications for cancer vaccine design (Cancer Research (2009) 69, (1046-54))

Lisa M Ebert, Y. C. Liu, C. S. Clements, N. C. Robson, H. M. Jackson, J. L. Markby, N. Dimopoulos, B. S. Tan, Immanuel F Luescher, I. D. Davis, J. Rossjohn, Jonathan Cebon, A. W. Purcell, W. Chen

Research output: Contribution to journalComment / DebateOtherpeer-review

Original languageEnglish
Pages (from-to)4553
Number of pages1
JournalCancer Research
Volume69
Issue number10
DOIs
Publication statusPublished - 15 May 2009

Cite this

Ebert, L. M., Liu, Y. C., Clements, C. S., Robson, N. C., Jackson, H. M., Markby, J. L., Dimopoulos, N., Tan, B. S., Luescher, I. F., Davis, I. D., Rossjohn, J., Cebon, J., Purcell, A. W., & Chen, W. (2009). A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: Implications for cancer vaccine design (Cancer Research (2009) 69, (1046-54)). Cancer Research, 69(10), 4553. https://doi.org/10.1158/0008-5472.CAN-69-10-COR2